While the available data support a role for CR in the CD8+ T cell-mediated control of the tumors, it is important to note that the tumors induced by B16-OVA cells also express the creatine transporter [102], leaving open the (yet untested) possibility that CR uptake could have an undefined effect on the tumor cells. The gene discussed is CD8A; the disease is neoplasm.